Your browser doesn't support javascript.
loading
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study.
Moretto, Roberto; Rossini, Daniele; Catteau, Aurélie; Antoniotti, Carlotta; Giordano, Mirella; Boccaccino, Alessandra; Ugolini, Clara; Proietti, Agnese; Conca, Veronica; Kassambara, Alboukadel; Pietrantonio, Filippo; Salvatore, Lisa; Lonardi, Sara; Tamberi, Stefano; Tamburini, Emiliano; Poma, Anello Marcello; Fieschi, Jacques; Fontanini, Gabriella; Masi, Gianluca; Galon, Jérôme; Cremolini, Chiara.
Afiliación
  • Moretto R; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Rossini D; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Catteau A; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Antoniotti C; Veracyte, Marseille, France.
  • Giordano M; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Boccaccino A; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Ugolini C; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Proietti A; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Conca V; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Kassambara A; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
  • Pietrantonio F; Unit of Pathological Anatomy 3, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Salvatore L; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Lonardi S; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Tamberi S; Veracyte, Marseille, France.
  • Tamburini E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Poma AM; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Fieschi J; Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Fontanini G; Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Masi G; Oncology Unit, Ravenna Hospital, AUSL Romagna, Ravenna, Italy.
  • Galon J; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.
  • Cremolini C; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
J Immunother Cancer ; 11(4)2023 04.
Article en En | MEDLINE | ID: mdl-37085190
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Italia